|
 |
| |
| |
| Licensing & Royalties >> Licensing Opportunities >> Abstract Details |
|
| |
| The First Immortalized Kaposi's Sarcoma Cell Line |
Description of Invention:
Kaposi's Sarcoma (KS) is the most common malignancy in patients with acquired immunodeficiency syndrome (AIDS) in the U.S. The present invention makes available cell lines that provide a means for testing anti-Kaposi's Sarcoma therapies in vitro, or a model animal system. The invention allows therapies to be tested and dosages to be optimized prior to testing in humans. The cell line also provides a means of developing novel antitumor therapies and facilitates studies of factors that influence the development and metastasis of malignancies.
Inventors:
Robert C Gallo (NCI)
Patent Status:
HHS, Reference No. E-116-1992/0
US, , Patent No. 5,569,602, Issued 29 Oct 1996
HHS, Reference No. E-116-1992/0
For Licensing Information Please Contact:
Uri Reichman Ph.D., M.B.A.
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325
Room 26,
Rockville, MD 20852
United States
Email: reichmau@mail.nih.gov
Phone: 301-435-4616
Fax: 301-402-0220
Ref No: 150
Updated: 04/1994
|
|
|
|
| |
|
|
|
|